Learn more about how cytokines drive the pain, joint destruction, and systemic complications of RA.
Find out how JAK proteins contribute to pathological signalling in RA.
Discover strategies to navigate COVID-19, including how to mitigate the risks and maintain optimal patient care.
Understand more about the significant burden of unresolved symptoms and their impact on patient quality of life.
Find out more about optimal strategies to improve outcomes for your patients with RA.
Gilead and Galapagos have joined forces and pooled their expertise. Now, in partnership with experts like you, we are taking on the challenges of RA to help patients living with the disease.To access the latest content on RA, including valuable teaching/learning materials, enter your information below.
By signing up to receive updates I consent to be contacted by Gilead Sciences Europe Ltd and by Galapagos NV by electronic means (such as e-mail or SMS) with information about Gilead’s and Galapagos’ products and services and/or pharmaceutical promotional materials. By law, Gilead and Galapagos are required to obtain your consent in order to send you these electronic communications. You have the right to opt-out of receiving such electronic communications, at any time, by contacting Gilead and/or Galapagos or by clicking the unsubscribe link contained in each mail sent by us.
Gilead and Galapagos may share your personal data with other Gilead and Galapagos affiliates and/or third party vendors who provide services to Gilead or Galapagos for the purposes of providing you with these updates, but Gilead and/or Galapagos shall remain responsible for the confidentiality and security of your personal data at all times. We will not sell or rent your personally identifiable information. For further information about how Gilead and Galapagos handle your personal data and your rights please read our privacy statements: https://www.gilead.com/privacy-statements and https://www.glpg.com/privacy-notice.
GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies. GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.
© 2020 Gilead Sciences, Inc. All rights reserved. IHQ-INF-2020-11-0017 12/20